CountryFocus: Key-Trends in The Healthcare Market, is expected to grow at a CAGR of 4.1% from $54.5B in 2018 to $59.4B in 2020

Posted on 2019-05-03 by Mark Hub in Pharmaceuticals // 0 Comments

Albany, US, 2019-May-03 — /EPR Network/ —It has been observed that, the global market for CountryFocus: Healthcare- Japan would be experiencing steady growth marked in million US$ by 2025. Such advancements can be attributed to the efforts put in by prime manufacturers operating in the global CountryFocus: Healthcare- Japan during the period. All such statistics and figures are carefully enclosed in a recently uploaded research report titled “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Japan”, onto its broad online database. Readers are enlightened about different aspects associated to the global CountryFocus: Healthcare- Japan which covers growth rate, revenue share, geographical market share, sales channel and Porter’s Five Forces analysis

Request Sample Copy of the Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2303797

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Japan

Summary
GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Japan”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Japan. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Japan. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

In 2010, the Japanese pharmaceutical market was worth $67.5B, which decreased to an estimated $61.8B in 2017 at a negative Compound Annual Growth Rate (CAGR) of 2%. The Japanese medical devices market was valued at $48.3B in 2015, which increased to $52.2B in 2017. The market is expected to grow at a CAGR of 4.1% from $54.5B in 2018 to $59.4B in 2020. Regulatory reforms have led to faster and more efficient drug approval processes. This has led to international pharmaceutical companies establishing R&D centers and increasing their investments in Japan.

Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Japan, and includes –
– An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
– Profiles and SWOT analyses of the major players in the pharmaceutical market (Daiichi Sankyo, Astellas, Roche, Takeda, and Otsuka) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Abbott, Roche, Terumo and Fujitsu)
– Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Japan
– Porters five forces analysis for pharmaceutical and medical devices market of Japan
– An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
– Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
– An overview of the opportunitiesand challenges to growth in the Japanese healthcare market.

Reasons to buy
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Japan, and includes –
– An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
– Profiles and SWOT analyses of the major players in the pharmaceutical market (Daiichi Sankyo, Astellas, Roche, Takeda, and Otsuka) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Abbott, Roche, Terumo and Fujitsu)
– Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Japan
– Porters five forces analysis for pharmaceutical and medical devices market of Japan
– An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
– Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
– An overview of the opportunities for and challenges to growth in the Japanese healthcare market.

Browse Full Report with TOC@ https://www.marketresearchhub.com/report/countryfocus-healthcare-regulatory-and-reimbursement-landscape-japan-report.html

Table of Contents
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porters Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

Continued……….@#

Enquire about this report@ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=2303797

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like Pharmaceuticals market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick